XML 76 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Business Description (Tables)
 12 Months Ended
Sep. 30, 2023
Organization and Business Description [Abstract]  
Schedule of Consolidated Financial Statements of the Company The consolidated financial statements of the Company include the following entities:
Name of Entity  Date of
Incorporation		   Place of
Incorporation		  % of
Ownership		   Principal Activities
Jin Med   January 14, 2020    Cayman Island   Parent    Investment holding
                 
Zhongjin HK   February 25, 2020    Hong Kong   100%  Investment holding
                 
Erhua Med   September 24, 2020    PRC   100%  WFOE, Investment holding
                 
Changzhou Zhongjin   January 26, 2006    PRC   VIE    Design, development, manufacturing and sales of wheelchair and other mobility products
                 
Taizhou Zhongjin   June 17, 2013    PRC   100% controlled subsidiary of the VIE    Design, development, manufacturing and sales of wheelchair and other mobility products
                 
Zhongjin Jing’ao   December 18, 2014    PRC   100% controlled subsidiary of the VIE    Design, development, manufacturing and sales of wheelchair and other mobility products
                 
Zhongjin Kangma   August 21, 2023   PRC   80% controlled subsidiary of the VIE   Newly incorporated – not in operation yet
                 
Anhui Zhongjin   October 7, 2023   PRC   100%  Newly incorporated – not in operation yet
Schedule of Financial Statement Amounts and Balances of the VIE and VIE’s Subsidiaries The following financial statement amounts and balances of the VIE and VIE’s subsidiaries were included in the accompanying consolidated financial statements after elimination of intercompany transactions and balances:
   September 30,
2023		   September 30,
2022		 
Current assets  $24,391,558   $18,903,147 
Non-current assets   1,787,635    2,036,387 
Total assets  $26,179,193   $20,939,534 
Current liabilities  $8,763,714   $5,703,843 
Non-current liabilities   
-
    
-
 
Total liabilities  $8,763,714   $5,703,843 
Schedule of Revenue
   For the Years Ended September 30, 
   2023   2022   2021 
Net revenue  $19,821,457   $19,190,541   $20,764,273 
Net income  $3,438,466   $2,706,527   $2,631,706 
Schedule of Cash Flow Statement
   For the Years Ended September 30, 
   2023   2022   2021 
Net cash provided by operating activities  $3,566,639   $1,580,656   $5,843,292 
Net cash used in investing activities   (2,430,248)   (120,904)   (1,067,640)
Net cash (used in) provided by financing activities  $(213,892)  $121,855   $(2,870,219)